smouldering myeloma

smouldering myeloma

A slowly progressive myeloma with an average survival of 10 years, which contrasts with untreated (6-month survival) and treated (3- to 5-year survival) myelomas. Indolent myeloma comprises 5% of myelomas and is often detected by routine lab tests for unrelated reasons; most patients have stage-I disease.
Mentioned in ?
References in periodicals archive ?
Additional studies are ongoing or planned to assess its potential in other malignant and pre-malignant diseases in which CD38 is expressed, such as smouldering myeloma and non-Hodgkin lymphoma.
Janssen Submits Marketing Authorisation Application for Daratumumab for European Patients With Heavily Pre-treated Multiple Myeloma

Medical browser ?
Full browser ?